WCM
PFE icon

Winthrop Capital Management’s Pfizer PFE Stock Holding History

Winthrop Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$305K Buy
12,660
+85
+0.7% +$2.22K 0.07% 106
2026
Q1 		$353K Buy
12,575
+422
+3% +$11.2K 0.09% 101
2025
Q4 		$303K Sell
12,153
-1,833
-13% -$46.2K 0.07% 111
2025
Q3 		$356K Sell
13,986
-1,007
-7% -$24.9K 0.09% 102
2025
Q2 		$363K Sell
14,993
-17,367
-54% -$405K 0.09% 104
2025
Q1 		$820K Sell
32,360
-228
-0.7% -$5.97K 0.23% 76
2024
Q4 		$861K Buy
+32,588
New +$884K 0.23% 79
2024
Q1 		– Sell
-19,302
Closed -$556K – 251
2023
Q4 		$556K Buy
+19,302
New +$583K 0.18% 90

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Winthrop Capital Management's PFE Position: Q2 2026 in Review

Winthrop Capital Management increased its Pfizer (PFE) stake by 0.68% in Q2 2026, buying an estimated $2.22K and bringing the position to 12,660 shares worth $305K. The position accounts for 0.07% of the portfolio, ranked #106.

Winthrop Capital Management first reported a position in PFE in Q4 2023 and has held it in 8 quarters since. The position peaked at $861K in Q4 2024. 2,836 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Winthrop Capital Management held 12,660 shares of Pfizer worth $305K as of Q2 2026.
  • Winthrop Capital Management bought 85 Pfizer shares in Q2 2026, an estimated $2.22K.
  • Pfizer made up 0.07% of Winthrop Capital Management's portfolio in Q2 2026, its #106 holding.
  • Winthrop Capital Management first reported a position in Pfizer in Q4 2023 and has held it in 8 quarters since.
  • Winthrop Capital Management's Pfizer position peaked at $861K in Q4 2024.
  • 2,836 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Winthrop Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.